Rifaximin for Infection Prophylaxis in Hematopoietic Stem Cell Transplantation
Clinical trial NCT03529825 · COMPLETED
Trial details
- NCT number
- NCT03529825
- Sponsor
- Emory University
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-18
- Primary completion
- 2020-10-19
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.